BIOPHARMACEUTICAL COMMERCIAL, MARKET ACCESS & CORPORATE STRATEGY CONSULTANTS

TS BioAdvisors (TSBA) provides tailored global commercial, marketing and market access strategy consulting and fractional commercial leadership to the biopharma industry, with a focus on cell and gene therapy (CGT) and rare disease innovators

OUR EXPERTISE

TS BIOADVISORS: OUR APPROACH TO SERVING OUR CLIENTS

Pragmatic strategies and plans built for real stakeholder dynamics, tailored to client stage and executional realities.

Our mission is to help our clients craft and execute insights-driven global commercialization, market access, value demonstration, and go-to-market strategies that maximize the long-term commercial, strategic partnership, and financing potential of their pioneering, high-value products.

We use our deep expertise in cell, gene and rare disease therapies to address the unique product, market, competitive, payer, health system, and other dynamics that shape the long-term value and commercial success of these programs.

As stakeholder expectations evolve, clinical and program strategies must reflect more than regulatory requirements. We bring payer, provider, patient/caregiver, and health system considerations into planning early, when smart early commercial strategic decisions and investments can have the highest long-term impact.

We work with companies from Pre-IND through launch, and we encourage early commercial, value demonstration, and market access work well before clinical proof of concept.

We are scientifically and clinically savvy. We translate scientific and clinical innovation into clear commercial advantage and decisions.

We don’t deliver generic, templated plans that sit unused. We work alongside leadership and subject - matter experts to co-create strategies and implementable plans that set you and your current or eventual strategic partners up for commercial success.

ABOUT TSBA →

ABOUT TED SLOCOMB, TSBA FOUNDER & MANAGING PARTNER

Our unique value to our clients is grounded in Ted Slocomb's 30+ years of biopharma industry experience, including 12+ years in CGT commercialization and market access leadership.

Held VP-level commercial and market access leadership roles at Kite Pharma (a Gilead Company), Astellas Gene Therapies, and Audentes Therapeutics.
Served as Global Commercial Leader of MYALEPT and for the obesity franchise at Amylin Pharmaceuticals.
Invested in private biopharma firms as a Principal at the Bear Stearns Health Innoventures VC fund.
Former co-chair, Value & Access Committee, Alliance for Regenerative Medicine (ARM).

VIEW TED’S FULL BIO ON LINKEDIN →

ABOUT TS BIOADVISORS

A California-based boutique advisory built for high-stakes launches.

TS BioAdvisors is a California-based boutique strategy consulting practice. We help biopharma innovators build tailored global commercialization, market access, value demonstration, and go-to-
market strategies that maximize long-term commercial potential.

Many TSBA clients are CGT first movers entering new disease areas and indications. They rely on TSBA to develop ground-up strategies and plans for pioneering applications, supported by a deep network of longtime experts in the space.

Our work is informed by hard-won, real-world leadership experience. We bring practical perspectives on the organizational capabilities, investments, operating model, and cultural considerations required for CGT launch readiness and commercial success.

HOW WE HELP OUR CLIENTS!

Flexible support that fits stage, ambition, and resourcing reality.

Every engagement is tailored. In our experience, the tools, decision processes, and resourcing intensity
that fit a pre-proof-of-concept program differ materially from what is needed to prepare for a first launch. Below is a selection of the types of deliverables we offer, as well as additional capacities in which we serve our clients.

We can provide fractional or interim commercial leadership reporting to C-level or other internal champion.
Engagements are typically structured as a monthly retainer or project-based fee, with hourly support also available for certain ad hoc needs.
We can help select and manage a key vendor network on a client’s behalf and often oversee and coordinate planning and execution of key commercial and market access work with a client’s other vendors.

DELIVERABLES & CAPABILITIES WE OFFER

EARLY PROGRAM PLANNING

Generate foundational market & stakeholder insights (early commercial planning, pre-POC).
Co-create Target Product Profile with program team to shape clinical and evidence generation plans (early commercial, pre-POC).
Set early product vision and strategic positioning (pre-POC).
Set early pricing vision and access assumptions and plans (market access and HEOR).
Create value evidence generation roadmap (market access and HEOR).
Review revenue, P&L, and valuation model inputs (financial and portfolio).
Support portfolio prioritization and go/no-go decisions (financial and portfolio).

COMMERCIAL, MARKET ACCESS STRATEGY & LAUNCH READINESS

Build global brand and go-to-market strategy (POC to launch).
Define pricing & market access plan including global launch sequencing and priorities (market access and HEOR).
Build HTA and payer engagement plan (market access and HEOR).
Define launch workstreams, milestones, and decision points, set up LRRs (launch readiness).
Refresh global brand strategy and lifecycle plan, prioritize new indications (in-market products).

CORPORATE STRATEGY, OPERATIONAL PLANNING & BD SUPPORT

Design structure and phasing of global commercial, market access, and HEOR organization (operating model).
Build functional headcount and operating expense plans aligned to development stage (operating model).
Prepare commercial diligence readiness materials (BD and corporate development).
Represent commercial perspective in diligence discussions, ingoing and outgoing (BD and corporate development).
Clearly define and help leadership communicate commercial potential (investor messaging).

CONTACT US TO DISCUSS A SOLUTION TO YOUR UNIQUE OPPORTUNITIES, CHALLENGES AND NEEDS.

Contact Ted Slocomb, Founder and Managing Partner, at tslocomb@tsbioadvisors.com to discuss how
TSBA can support your commercialization and corporate goals.